Prelude Therapeutics Semi Variance
| PRLD Stock | | | USD 3.84 0.24 6.67% |
The Semi Variance technical lookup provides context for Prelude Therapeutics and related instruments. Coverage depends on data availability and normalization;
Equity Screeners provides additional screening context. Prelude Therapeutics has market cap of 226.31 M, operating margin of -3.14%, ROE of -103.99%. Review
Your Equity Center for broader portfolio context. This reflects a position in Prelude Therapeutics in the portfolio view. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in board of governors.
Our
How to Invest in Prelude Therapeutics guide provides practical guidance on trading Prelude Stock.
Prelude Therapeutics has current Semi Variance of 34.88. Semi-variance provides a good measure of downside volatility for equity or a portfolio. It is similar to variance, but it only looks at periods where the returns are less than the target or average level.
Semi Variance | = | SUM(RET DEV)2N(ZERO) |
| = | 34.88 | |
| SUM | = | Summation notation |
| RET DEV | = | Actual return deviation over selected period |
| N(ZERO) | = | Number of points with returns less than zero |
Prelude Therapeutics Semi Variance Peers Comparison
Prelude Semi Variance Relative To Other Indicators
Prelude Therapeutics maintains a
second in Semi Variance in semi variance category among its top compatitors. It is currently under evaluation. in maximum drawdown category among its top compatitors reporting about
1.04 of Maximum Drawdown per Semi Variance. The ratio of Maximum Drawdown to Semi Variance for Prelude Therapeutics is roughly
1.04 Semi-variance is the square of semi-deviation. Semi-variance is calculated by averaging the deviations of returns that have a result that is less than the mean.
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.